Alawieh Ali, Zohdy Youssef M, El Annan Rim, Assi Jad H, Dimisko Laurie, Grossberg Jonathan A, Cawley C Michael, Chandler Katherine, Chern Joshua J, Sawvel Michael S, Brahma Barunashish, Garzon-Muvdi Tomas, Pradilla Gustavo, Barrow Daniel, Reisner Andrew, Howard Brian M
Department of Neurosurgery, Emory University, Atlanta, Georgia, USA.
Emory Healthcare, Atlanta, Georgia, USA.
J Neurointerv Surg. 2024 Jan 3;17(5):478-486. doi: 10.1136/jnis-2023-021195.
Infectious intracranial aneurysms (IIAs) are a rare sequel of systemic infection and occur most commonly in patients with infective endocarditis (IE). Despite the increasing use of non-invasive screening angiography in patients with IE, the incidence remains low, yielding limited data on the management of IIAs in pediatric populations. We performed a pooled analysis of all published series of pediatric patients with IIAs to study the disease landscape including presentation, management, and outcomes.
Data included in this study were pooled from published literature on IIAs between 1960 and 2023. Abstracts were selected for full review to include only manuscripts reporting at least one case of pediatric IIA (age 0-18 years).
A total of 145 pediatric patients with 178 IIAs were included. Patients presented with rupture in 68% of cases, of which 36% had intraparenchymal hemorrhage and 39% had subarachnoid hemorrhage. Using multivariate logistic regression, independent predictors of rupture were posterior location (aOR 10, P=0.041) and history of IE (aOR 7.2, P=0.001). Primary medical management was successful in 82% of cases with unruptured aneurysms while, in those with ruptured IIAs, medical management was successful in 26% of cases. The 90-day mortality rate was 28%. Using multivariate logistic regression, ruptured IIAs (aOR 5.4, P<0.01) and failure of medical management (aOR 11.1, P<0.05) were independent predictors of 90-day mortality.
Pediatric IIAs remain a rare complication of systemic or localized CNS infection in the pediatric population. Medical management of unruptured aneurysms is highly successful, while ruptured aneurysms have a remarkably high rate of failure of medical management and should be treated by early surgical or endovascular intervention when feasible.
感染性颅内动脉瘤(IIA)是全身感染的一种罕见后遗症,最常见于感染性心内膜炎(IE)患者。尽管在IE患者中越来越多地使用非侵入性筛查血管造影,但发病率仍然很低,关于儿科人群IIA管理的数据有限。我们对所有已发表的儿科IIA患者系列进行了汇总分析,以研究该疾病的情况,包括临床表现、管理和结局。
本研究纳入的数据来自1960年至2023年期间发表的关于IIA的文献。摘要被选出来进行全面审查,仅纳入报告至少一例儿科IIA(年龄0至18岁)的手稿。
共纳入145例患有178个IIA的儿科患者。68%的病例出现动脉瘤破裂,其中36%发生脑实质内出血,39%发生蛛网膜下腔出血。使用多因素逻辑回归分析,破裂的独立预测因素为动脉瘤位于后部(调整后比值比[aOR]为10,P = 0.041)和有IE病史(aOR为7.2,P = 0.001)。对于未破裂的动脉瘤,82%的病例主要药物治疗成功;而对于破裂的IIA,药物治疗在26%的病例中成功。90天死亡率为28%。使用多因素逻辑回归分析,破裂的IIA(aOR为5.4,P < 0.01)和药物治疗失败(aOR为11.1,P < 0.05)是90天死亡率的独立预测因素。
儿科IIA仍然是儿科人群全身或局部中枢神经系统感染的罕见并发症。未破裂动脉瘤的药物治疗非常成功,而破裂动脉瘤的药物治疗失败率非常高,应在可行时尽早进行手术或血管内介入治疗。